Analysis of 27 Cases of Anaphylactoid Reactions Caused by Magnesium Isoglycyrrhizinate Injection
10.6039/j.issn.1001-0408.2016.29.14
- VernacularTitle:异甘草酸镁注射液致过敏样反应27例分析
- Author:
Jia LUO
;
Guangjian CHEN
;
Liping YANG
;
Yi WU
;
Lizhi CAO
- Publication Type:Journal Article
- Keywords:
Magnesium isoglycyrrhizinate injection;
Anaphylactoid reactions;
Adverse drug reaction;
Analysis
- From:
China Pharmacy
2016;27(29):4080-4082
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the regularity and characteristics of anaphylactoid reactions induced by Magnesium iso-glycyrrhizinate injection,and provide reference for clinical rational drug use. METHODS:27 ADR reports induced by Magnesium isoglycyrrhizinate injection from Hunan Center for ADR Monitoring from Jan. 2014 to Mar. 2015 were retrospectively analyzed. RE-SULTS:In the 27 cases,15 were male (55.56%) and 12 were female (44.44%),with percentage of 1.25∶1;ADR mainly oc-curred in patients with 41-60 years old(51.85%);involved organ/system were mainly skin and its appendages(35.85%)and sys-temic damage(26.42%),the main clinical manifestations were rash,itching,fever,chills,vomiting and dizziness;there were 7 severe ADR reports(25.92%),mainly showed chills,fever and other systemic symptoms;most ADR can be cured(40.74%)or relieved(55.56%)by related processing. CONCLUSIONS:There are no risk tips for severe allergic reactions in instruction,it is necessary to strengthen post-marketing surveillance and further improve the drug instructions to reduce the risk of severe ADR in-duced by Magnesium isoglycyrrhizinate injection.